211 related articles for article (PubMed ID: 16604677)
41. [A beta ray applicator (106Ru/106Rh) in the treatment of ciliary body melanomas].
Ballin R; Lommatzsch PK; Drost H; Ratajek B
Klin Monbl Augenheilkd; 1985 Aug; 187(2):144-6. PubMed ID: 4057906
[TBL] [Abstract][Full Text] [Related]
42. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
Miras H; Terrón JA; Lallena AM
Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
[TBL] [Abstract][Full Text] [Related]
43. The effects of variations in the density and composition of eye materials on ophthalmic brachytherapy dosimetry.
Asadi S; Masoudi SF; Shahriari M
Med Dosim; 2012; 37(1):1-4. PubMed ID: 21723111
[TBL] [Abstract][Full Text] [Related]
44. Dosimetric and radiobiologic comparison of
Gorovets D; Gagne NL; Melhus CS
Brachytherapy; 2017; 16(2):433-443. PubMed ID: 28161431
[TBL] [Abstract][Full Text] [Related]
45. Fluorescein angiography in the follow-up study of choroidal melanoma after 106Ru/106Rh plaque therapy.
Lommatzsch PK; Ballin RE; Helm W
Retina; 1987; 7(3):148-55. PubMed ID: 3423430
[TBL] [Abstract][Full Text] [Related]
46. Calculation of dose distributions for 12 106Ru/106Rh ophthalmic applicator models with the PENELOPE Monte Carlo code.
Hermida-López M
Med Phys; 2013 Oct; 40(10):101705. PubMed ID: 24089895
[TBL] [Abstract][Full Text] [Related]
47. Dose characteristics of Au-198 eye brachytherapy applicator: A Monte Carlo study.
Kamrani S; Aghamiri SMR; Hashemi S
Appl Radiat Isot; 2021 Oct; 176():109866. PubMed ID: 34293507
[TBL] [Abstract][Full Text] [Related]
48. Novel low-kVp beamlet system for choroidal melanoma.
Esquivel C; Fuller CD; Waggener RG; Wong A; Meltz M; Blough M; Eng TY; Thomas CR
Radiat Oncol; 2006 Sep; 1():36. PubMed ID: 16965624
[TBL] [Abstract][Full Text] [Related]
49. COMS eye plaque brachytherapy dosimetric sensitivity to source photon energy and seed design.
Gagne NL; Rivard MJ
Appl Radiat Isot; 2013 Sep; 79():62-6. PubMed ID: 23728350
[TBL] [Abstract][Full Text] [Related]
50. A patch source model for treatment planning of ruthenium ophthalmic applicators.
Astrahan MA
Med Phys; 2003 Jun; 30(6):1219-28. PubMed ID: 12852546
[TBL] [Abstract][Full Text] [Related]
51. Experimental validation of a new COMS-like 24 mm eye plaque for the treatment of large ocular melanoma tumors.
McCauley Cutsinger S; Forsman R; Corner S; Deufel CL
Brachytherapy; 2019; 18(6):890-897. PubMed ID: 31444131
[TBL] [Abstract][Full Text] [Related]
52. A practical method of estimating medium-heterogeneity corrected dose without a Monte Carlo calculation in ocular brachytherapy using
Lee YC; Nik Akhtar M; Kim Y; Jung JW
Brachytherapy; 2024; 23(3):377-386. PubMed ID: 38336557
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of dose enhancement in presence of gold nanoparticles in eye brachytherapy by
Rezaei H; Zabihzadeh M; Ghorbani M; Goli Ahmadabad F; Mostaghimi H
Australas Phys Eng Sci Med; 2017 Sep; 40(3):545-553. PubMed ID: 28509080
[TBL] [Abstract][Full Text] [Related]
54. [Brachytherapy of ocular melanoma: physical and dosimetric aspects of 125I plaques].
Bard JJ
Bull Cancer Radiother; 1995; 82(3):295-305. PubMed ID: 8554879
[TBL] [Abstract][Full Text] [Related]
55. Monte Carlo calculation of the dose distributions of two 106Ru eye applicators.
Sánchez-Reyes A; Tello JI; Guix B; Salvat F
Radiother Oncol; 1998 Nov; 49(2):191-6. PubMed ID: 10052886
[TBL] [Abstract][Full Text] [Related]
56. Monte Carlo dosimetry of the eye plaque design used at the St. Erik Eye Hospital for (125)I brachytherapy.
Karlsson M; Nilsson J; Lundell M; Carlsson Tedgren A
Brachytherapy; 2014; 13(6):651-6. PubMed ID: 24950821
[TBL] [Abstract][Full Text] [Related]
57. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator.
Poon E; Williamson JF; Vuong T; Verhaegen F
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1259-66. PubMed ID: 18954720
[TBL] [Abstract][Full Text] [Related]
58. Dosimetric comparison of 106Ru and 125I plaques for treatment of shallow (Wilkinson DA; Kolar M; Fleming PA; Singh AD
Br J Radiol; 2008 Oct; 81(970):784-9. PubMed ID: 18628320
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
[TBL] [Abstract][Full Text] [Related]
60. Comparison of dose distributions around the pulsed-dose-rate Fletcher-Williamson and the low-dose-rate Fletcher-Suit-Delclos ovoids: a Monte Carlo study.
Price MJ; Gifford KA; Horton J; Lawyer A; Eifel P; Mourtada F
Phys Med Biol; 2006 Aug; 51(16):4083-94. PubMed ID: 16885626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
